| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 847173-28-8 | 6,8-Dimethyl-2,3,4,5-tetrahydro-1H-1-benzazepine | C12H17N |
| 847173-36-8 | 8-Fluoro-2,3,4,5-Tetrahydro-1H-Benzo[b]Azepine Hydrochloride | |
| 847180-48-7 | 2-[7-[3-(5-Carboxypentyl)-1,3-dihydro-1,1-dimethyl-6,8-disulfo-2H-benz[e]indol-2-ylidene]-1,3,5-heptatrien-1-yl]-3-ethyl-1,1-dimethyl-6,8-disulfo-1H-benz[e]indolium inner salt | C43H46N2O14S4 |
| 847203-30-9 | 2-Methyl-N-(3-methyl-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)propanamide | C7H12N4O2 |
| 847225-56-3 | 4-Fluoro-2-pyridinecarbonitrile | C6H3FN2 |
| 847227-37-6 | 5-Butyl-2-chloropyrimidine | C8H11ClN2 |
| 847227-46-7 | 4-Cyanomandelic Acid Ethyl Ester | C11H11NO3 |
| 847229-95-2 | Tumor antigen 17-1A (human HLA-A2402-restricted cytotoxic T lymphocyte 9-amino acid epitope) | C56H86N14O14 |
| 847248-44-6 | 6-(3,4-Dihydro-2H-pyrrol-5-yl)quinoline | C13H12N2 |
| 847255-02-1 | N-1H-Indol-5-ylformamide | C9H8N2O |
| 847256-33-1 | Smac Inhibitor 1 | C26H34N4O3 |
| 847264-30-6 | 3-(2-Bromophenyl)pyridine | C11H8BrN |
| 847268-24-0 | (1S,2S)-1,2-Cyclopropanediylbiscarbamic acid bis(1,1-dimethylethyl) ester | C13H24N2O4 |
| 847268-25-1 | [(1S,2S)-2-Aminocyclopropyl]carbamic acid 1,1-dimethylethyl ester | C8H16N2O2 |
| 847345-37-3 | 2-Methoxy-5-ethylphenylboronic acid | C9H13BO3 |
| 847348-15-6 | 4-Chloro-1-methoxy-2-phenoxybenzene | C13H11ClO2 |
| 847348-48-5 | 3-[2-Methyl-4-(Phenylmethoxy)Phenyl]-2-Propenoic Acid Methyl Ester | C18H18O3 |
| 847375-16-0 | WAY 267464 | C32H35N7O4 |
| 847375-52-4 | 1,4-Dichloro-2-butanol | C4H8Cl2O |
| 847406-37-5 | (betaS,4R)-beta-Methyl-gama,2-dioxo-4-(phenylmethyl)-3-oxazolidinebutanoic acid tert-butyl ester | C19H25NO5 |
| 847416-70-0 | cis-(1,1-Dimethylethoxy)carbonyl Tranexamic Acid | C13H23NO4 |
| 847416-99-3 | tert-Butyl (3-oxocyclopentyl)carbamate | C10H17NO3 |
| 847440-49-7 | O-(Methylthio)methyl Triptolide | C22H28O6S |
| 847445-17-4 | (1-oxobutyl)-Sulfamoyl chloride | C4H8ClNO3S |
| 847445-81-2 | 7-[1-Oxo-3-amino-4-(2,4,5-trifluorophenyl)but-2-enyl]-3-trifluoromethyl-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine | C16H13F6N5O |
| 847446-55-3 | Ethyl 8-bromo-6-methylimidazo[1,2-a]pyridine-2-carboxylate | C11H11BrN2O2 |
| 847446-84-8 | 4-(3-Methyl-2-pyridinyl)benzaldehyde | C13H11NO |
| 847446-85-9 | 4-[3-(Trifluoromethyl)-2-pyridinyl]benzaldehyde | C13H8F3NO |
| 847446-86-0 | 4-(3-Chloro-2-pyridinyl)benzaldehyde | C12H8ClNO |
| 847446-88-2 | 4-[3-(Trifluoromethyl)-2-pyridinyl]benzoic acid | C13H8F3NO2 |
| 847446-89-3 | 4-(3-Nitro-2-pyridinyl)benzoic acid | C12H8N2O4 |
| 847448-73-1 | 3-Formyl-6-Methoxyindole-1-Carboxylic Acid Tert-Butyl Ester | C15H17NO4 |
| 847458-97-3 | 4-Amino-3-methyl-1-piperidinecarboxylic acid benzyl ester | C14H20N2O2 |
| 847490-69-1 | 4-Iodoisoxazole | C3H2INO |
| 847490-98-6 | 4-Oxazolemethanamine, Hydrochloride | C4H7ClN2O |
| 847491-00-3 | Oxazol-5-yl-methylamine hydrochloride | C4H6N2O.HCl |
| 847494-64-8 | N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxamide | C31H42BN3O5 |
| 847499-27-8 | Delanzomib | C21H28BN3O5 |
| 847499-95-0 | 1-(2-Amino-Ethyl)-Piperidin-3-Ol | |
| 847502-81-2 | 3,4-Difluoro-2-methylbromobenzene | C7H5BrF2 |
| 847502-83-4 | 3,4-Difluoro-2-methylbenzonitrile | C8H5F2N |
| 847502-84-5 | 3,4-Difluoro-2-methylbenzaldehyde | C8H6F2O |
| 847502-87-8 | 2,4-Difluoro-3-methylbenzonitrile | C8H5F2N |
| 847502-88-9 | 2,4-Difluoro-3-methylbenzaldehyde | C8H6F2O |
| 847502-90-3 | 1-(2,4-Difluoro-3-methylphenyl)methanamine | C8H9F2N |
| 847505-83-3 | 3-Bromo-7-methoxy-1-naphthonitrile | C12H8BrNO |
| 847547-06-2 | 5-Nitro-2-(trifluoromethyl)benzoic acid | C8H4F3NO4 |
| 847547-91-5 | 2-Chloro-3-hydroxyquinoline-4-carboxylic acid | C10H6ClNO3 |
| 847551-00-2 | 3-Iodo-1-(2-C-methyl-beta-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C11H14IN5O4 |
| 847551-25-1 | 7-[3,5-Bis-O-[(2,4-Dichlorophenyl)Methyl]-2-C-Methyl-beta-D-Ribofuranosyl]-4-Chloro-5-Iodo-7H-Pyrrolo[2,3-d]Pyrimidine |